copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Titan Pharmaceuticals, Inc. (TTNP) Titan Pharmaceuticals, Inc Nasdaq: TTNP Volume Day Low High 52-Week Low High Average Volume January 17, 2025 Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research: Read Article
About Titan Pharmaceuticals Titan Pharmaceuticals, Inc was incorporated as a Delaware corporation in 1992 Titan previously focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura®, for the treatment of select chronic diseases for which steady state delivery of a drug has the potential to provide an efficacy and or safety
Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP) In December 2021, Titan announced its intention to work with a financial advisor to explore strategic alternatives to enhance stockholder value, potentially including an acquisition, merger, reverse merger, other business combination, sales of assets, licensing or other transaction
Kappa Opioid Receptor Agonist - Titan Pharmaceuticals, Inc. In October 2020, Titan entered into an Asset Purchase Agreement with JT Pharmaceuticals, Inc , or JT Pharma, for the acquisition and development of JT Pharma’s kappa opioid agonist peptide, TP-2021 (formerly JT-09), for use in combination with the ProNeura technology
Profile :: Titan Pharmaceuticals, Inc. (TTNP) Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock
Company Information :: Titan Pharmaceuticals, Inc. (TTNP) Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock
Titan Pharmaceuticals to Explore Strategic Alternatives SOUTH SAN FRANCISCO, Calif , Dec 21, 2021 PRNewswire -- Titan Pharmaceuticals, Inc (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder value
Titan Pharmaceuticals Provides a Strategic Corporate Update Titan Pharmaceuticals, Inc (NASDAQ:TTNP), based in South San Francisco, CA, is a commercial stage company developing proprietary therapeutics with its ProNeura® long-term, continuous drug delivery technology